長鴻高科(605008.SH):全生物降解新材料產業園項目簽約落户嵊州
格隆匯10月30日丨長鴻高科(605008.SH)宣佈,2020年10月29日,年產60萬噸全生物降解熱塑性塑料產業園PBAT/PBS/PBT靈活柔性生產項目選址在浙江省紹興市嵊州市,公司與嵊州市人民政府簽訂了《全生物降解新材料產業園項目投資協議書》。
項目總投資約50億元人民幣,計劃用地213畝,一次規劃,分兩期實施,每期建設年產30萬噸PBAT、PBS、PBT等可降解材料柔性生產線,總建設週期為5年。其中一期投資25億元,一期首次投資10億元,二期投資尚需公司履行審議程序與信披義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.